NovaBay Pharmaceuticals Inc (NBY)
0.1045
+0.02
(+24.40%)
USD |
NYAM |
May 15, 16:00
0.102
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Cash from Financing (Quarterly): -0.597M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.597M |
| December 31, 2023 | -0.026M |
| September 30, 2023 | -0.577M |
| June 30, 2023 | 2.513M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 3.035M |
| September 30, 2022 | 1.703M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.105M |
| December 31, 2021 | 14.80M |
| September 30, 2021 | 0.219M |
| June 30, 2021 | 1.775M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.005M |
| September 30, 2020 | 6.013M |
| June 30, 2020 | 4.108M |
| March 31, 2020 | -0.364M |
| December 31, 2019 | -0.654M |
| September 30, 2019 | 6.852M |
| June 30, 2019 | 2.52M |
| March 31, 2019 | 2.984M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.006M |
| March 31, 2018 | 5.603M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.065M |
| September 30, 2017 | 0.146M |
| June 30, 2017 | 0.038M |
| March 31, 2017 | -0.048M |
| December 31, 2016 | 0.858M |
| September 30, 2016 | 9.824M |
| June 30, 2016 | 4.746M |
| March 31, 2016 | 3.994M |
| December 31, 2015 | 3.568M |
| September 30, 2015 | 0.337M |
| June 30, 2015 | 7.043M |
| March 31, 2015 | 4.653M |
| December 31, 2014 | 0.42M |
| September 30, 2014 | 0.359M |
| June 30, 2014 | 0.051M |
| March 31, 2014 | 6.556M |
| December 31, 2013 | 7.018M |
| September 30, 2013 | 1.832M |
| June 30, 2013 | 0.447M |
| March 31, 2013 | 0.03M |
| December 31, 2012 | 8.186M |
| September 30, 2012 | 1.314M |
| June 30, 2012 | 0.007M |
| March 31, 2012 | -0.035M |
| December 31, 2011 | 0.122M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.654M
Minimum
Dec 2019
14.80M
Maximum
Dec 2021
2.061M
Average
0.112M
Median
Cash from Financing (Quarterly) Benchmarks
| Eyenovia Inc | 0.6143M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.572M |
| Cash from Investing (Quarterly) | 1.068M |
| Free Cash Flow | -4.524M |
| Free Cash Flow Per Share (Quarterly) | -0.0638 |
| Free Cash Flow to Equity (Quarterly) | -1.444M |
| Free Cash Flow Yield | -395.6% |